Use of implantable cardioverter defibrillators in patients with left ventricular assist devices

European Journal of Heart Failure

Volumn 14, Issue 7, 2012, Pages 696-702

  Pettit, Stephen J ^a   Petrie, Mark C ^a   Connelly, Derek T ^a   Japp, Alan G ^a   Payne, John R ^a   Haj Yahia, Saleem ^a   Gardner, Roy S ^a  

^a GOLDEN JUBILEE NATIONAL HOSPITAL   (United Kingdom)

Author keywords

Implantable cardioverter defibrillator; Left ventricular assist device; Ventricular fibrillation; Ventricular tachycardia

Indexed keywords

DEFIBRILLATOR; HEART VENTRICLE ARRHYTHMIA; HUMAN; LEFT VENTRICULAR ASSIST DEVICE; MORTALITY; PRIORITY JOURNAL; REVIEW;

DEFIBRILLATORS, IMPLANTABLE; HEART-ASSIST DEVICES; HUMANS; RISK ASSESSMENT; STROKE VOLUME; TACHYCARDIA, VENTRICULAR; VENTRICULAR FIBRILLATION; VENTRICULAR FUNCTION, LEFT;

EID: 84862880887     PISSN: 13889842     EISSN: 18790844     Source Type: Journal    
DOI: 10.1093/eurjhf/hfs062     Document Type: Review

References (31)

1. Arai H, Swartz MT, Pennington DG, Moriyama Y, Miller L, Peigh P, McBride L. Importance of ventricular arrhythmias in bridge patients with ventricular assist devices. ASAIO Trans 1991;37:M427-M428.
2. Oz MC, Rose EA, Slater J, Kuiper JJ, Catanese KA, Levin HR. Malignant ventricular arrhythmias are well tolerated in patients receiving long-term left ventricular assist devices. J Am Coll Cardiol 1994;24:1688-1691. (Pubitemid 24369194)
3. Rose EA, Gelijns AC, Moskowitz AJ, Heitjan DF, Stevenson LW, Dembitsky W, Long JW, Ascheim DD, Tierney AR, Levitan RG, Watson JT, Meier P, Ronan NS, Shapiro PA, Lazar RM, Miller LW, Gupta L, Frazier OH, Desvigne-Nickens P, Oz MC, Poirier VL, Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) Study Group. Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med 2001;345:1435-1443.
4. Ziv O, Dizon J, Thosani A, Naka Y, Magnano AR, Garan H. Effects of left ventricular assist device therapy on ventricular arrhythmias. J Am Coll Cardiol 2005;45: 1428-1434. (Pubitemid 40615614)
5. Bedi M, Kormos R, Winowich S, McNamara DM, Mathier MA, Murali S. Ventricular arrhythmias during left ventricular assist device support. Am J Cardiol 2007;99: 1151-1153. (Pubitemid 46562514)
6. Refaat M, Chemaly E, Lebeche D, Gwathmey JK, Hajjar RJ. Ventricular arrhythmias after left ventricular assist device implantation. Pacing Clin Electrophysiol 2008;31: 1246-1252.
7. Andersen M, Videbaek R, Boesgaard S, Sander K, Hansen PB, Gustafsson F. Incidence of ventricular arrhythmias in patients on long-term support with a continuous-flow assist device (HeartMate II). J Heart Lung Transplant 2009;28: 733-735.
8. Slaughter MS, Rogers JG, Milano CA, Russell SD, Conte JV, Feldman D, Sun B, Tatooles AJ, Delgado RM, Long JW, Wozniak TC, Ghumman W, Farrar DJ, Frazier OH, HeartMate II Investigators. Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med 2009;361:2241-2251.
9. Pagani FD, Miller LW, Russell SD, Aaronson KD, John R, Boyle AJ, Conte JV, Bogaev RC, MacGillivray TE, Naka Y, Mancini D, Massey HT, Chen L, Klodell CT, Aranda JM, Moazami N, Ewald GA, Farrar DJ, Frazier OH, HeartMate II Investigators. Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device. J Am Coll Cardiol 2009;54:312-321.
10. Kirklin JK, Naftel DC, Kormos RL, Stevenson LW, Pagani FD, Miller MA, Ulisney KL, Baldwin JT, Young JB. Second INTERMACS annual report: more than 1,000 primary left ventricular assist device implants. J Heart Lung Transplant 2010;29:1-10.
11. Kühne M, Sakumura M, Reich SS, Sarrazin J-F, Wells D, Chalfoun N, Crawford T, BoonyapisitW, Horwood L, Chugh A, Good E, Jongnarangsin K, Bogun F, Oral H, Morady F, Pagani F, Pelosi F. Simultaneous use of implantable cardioverterdefibrillators left ventricular assist devices in patients with severe heart failure. Am J Cardiol 2010;105:378-382.
12. Brenyo A, Rao M, Koneru S, Hallinan W, Shah S, Massey HT, Chen L, Polonsky B, McNitt S, Huang DT, Goldenberg I, Aktas M. Risk of Mortality for Ventricular Arrhythmia in Ambulatory LVAD Patients. J Cardiovasc Electrophysiol;in press.
13. Oswald H, Schultz-Wildelau C, Gardiwal A, Lüsebrink U, Kö nig T, Meyer A, Duncker D, Pichlmaier MA, Klein G, Strüber M. Implantable defibrillator therapy for ventricular tachyarrhythmia in left ventricular assist device patients. Eur J Heart Fail 2010;12:593-599.
14. Boyle A. Arrhythmias in patients with ventricular assist devices. Curr Opin Cardiol 2012;27:13-18.
15. Harding JD, Piacentino V, Rothman S, Chambers S, Jessup M, Margulies KB. Prolonged repolarization after ventricular assist device support is associated with arrhythmias in humans with congestive heart failure. J Card Fail 2005;11:227-232. (Pubitemid 40462427)
16. Ambardekar AV, Buttrick PM. Reverse remodeling with left ventricular assist devices: a review of clinical, cellular, and molecular effects. Circ Heart Fail 2011; 4:224-233.
17. Nishimura M, Ogiwara M, Ishikawa M, Yatsu S, Masuoka A, Okamura N, Imanaka K, Kato M, Asano H, Kyo S. Fifteen-month circulatory support for sustained ventricular fibrillation by left ventricular assist device. J Thorac Cardiov Sur 2003;126:1190-1192. (Pubitemid 37305713)
18. Sims DB, Rosner G, Uriel N, Gonzalez-Costello J, Ehlert FA, Jorde UP. Twelve hours of sustained ventricular fibrillation supported by a continuous-flow left ventricular assist device. Pacing Clin Electrophysiol;in press.
19. Felix SEA, Martina JR, Kirkels JH, Klopping C, Nathoe H, Sukkel E, Hulstein N, Ramjankhan FZ, Doevendans PAFM, Lahpor JR, de Jonge N. Continuous-flow left ventricular assist device support in patients with advanced heart failure: points of interest for the daily management. Eur J Heart Fail 2012;14:351-356.
20. Lund LH, Matthews J, Aaronson K. Patient selection for left ventricular assist devices. Eur J Heart Fail 2010;12:434-443.
21. Brenyo A, Link MS, Barsheshet A, Moss AJ, Zareba W, Wang PJ, McNitt S, Huang D, Foster E, Estes M, Solomon SD, Goldenberg I. Cardiac resynchronization therapy reduces left atrial volume and the risk of atrial tachyarrhythmias in MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy). J Am Coll Cardiol 2011;58:1682-1689.
22. Ambardekar AV, Allen LA, Lindenfeld J, Lowery CM, Cannon AP, Cleveland JC, Brieke A, Sauer WH. Implantable cardioverter-defibrillator shocks in patients with a left ventricular assist device. J Heart Lung Transplant 2010;29:771-776.
23. Refaat MM, Tanaka T, Kormos RL, McNamara D, Teuteberg J, Winowich S, London B, Simon MA. Survival benefit of implantable cardioverter-defibrillators in left ventricular assist device-supported heart failure patients. J Card Fail 2012; 18:140-145.
24. Cantillon DJ, Tarakji KG, Kumbhani DJ, Smedira NG, Starling RC, Wilkoff BL. Improved survival among ventricular assist device recipients with a concomitant implantable cardioverter-defibrillator. Heart Rhythm 2010;7:466-471.
25. Foo D,Walker BD, Kuchar DL, Thorburn CW, Tay A, Hayward CS, Macdonald P, Keogh A, Kotlyar E, Spratt P, Jansz P. Left ventricular mechanical assist devices and cardiac device interactions: an observational case series. Pacing Clin Electrophysiol 2009;32:879-887.
26. Thoratec Corporation. Reported ICD experience. http://www.thoratec.com/ medical-professionals/reported-icd-experience.aspx (accessed 21 March 2012)
27. Johansen JB, Jørgensen OD, Møller M, Arnsbo P, Mortensen PT, Nielsen JC. Infection after pacemaker implantation: infection rates risk factors associated with infection in a population-based cohort study of 46299 consecutive patients. Eur Heart J 2011;32:991-998.
28. Authors/Task Force Members, Dickstein K, Vardas PE, Auricchio A, Daubert J-C, Linde C, McMurray J, Ponikowski P, Priori SG, Sutton R, Van Veldhuisen DJ, ESC Committee for Practice Guidelines (CPG), Vahanian A, Auricchio A, Bax J, Ceconi C, Dean V, Filippatos G, Funck-Brentano C, Hobbs R, Kearney P, McDonagh T, Popescu BA, Reiner Z, Sechtem U, Sirnes PA, Tendera M, Vardas P, Widimsky P, Document Reviewers, Tendera M, Anker SD, Blanc JJ, Gasparini M, Hoes AW, Israel CW, Kalarus Z, Merkely B, Swedberg K, Camm AJ. 2010 Focused Update of ESC Guidelines on device therapy in heart failure: an update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC guidelines for cardiac and resynchronization therapy. Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association. Eur Heart J 2010;31:2677-2687.
29. Mark DB, Anstrom KJ, Sun JL, Clapp-Channing NE, Tsiatis AA, Davidson-Ray L, Lee KL, Bardy GH, Sudden Cardiac Death in Heart Failure Trial Investigators. Quality of life with defibrillator therapy or amiodarone in heart failure. N Engl J Med 2008;359:999-1008.
30. Wilkoff BL, Williamson BD, Stern RS, Moore SL, Lu F, Lee SW, Birgersdotter-Green UM, Wathen MS, Van Gelder IC, Heubner BM, Brown ML, Holloman KK, PREPARE Study Investigators. Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study. J Am Coll Cardiol 2008;52: 541-550.
31. Gasparini M, Menozzi C, Proclemer A, Landolina M, Iacopino S, Carboni A, Lombardo E, Regoli F, Biffi M, Burrone V, Denaro A, Boriani G. A simplified biventricular defibrillator with fixed long detection intervals reduces implantable cardioverter defibrillator (ICD) interventions and heart failure hospitalizations in patients with non-ischaemic cardiomyopathy implanted for primary prevention: the RELEVANT [Role of long dEtection window programming in patients with LEft VentriculAr dysfunction, Non-ischemic eTiology in primary prevention treated with a biventricular ICD] study. Eur Heart J 2009;30:2758-2767.